Global Breast Cancer Diagnostics And Therapeutics Market Trends 2019 | Segmentation, Outlook, Industry Report to 2025

Global breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.4% during the forecast period. The growth of the market is attributed to the increasing prevalence of breast cancer and rising awareness in emerging countries such as India, China, and Malaysia. Furthermore, the introduction of new technology such as imaging technology and 3D mammography is also estimated to have a significant impact on the growth of the market. The global expenditure on breast cancer therapies and medicines is increasing very rapidly which leads to the high rates of diagnosis and treatment of breast cancer. However, the high cost of breast cancer drugs and surgeries across the developed countries are estimated to be the major constraints in the growth of the market. As per the American Cancer Society, breast cancer treatment can cost more than $100,000 in developed countries such as the US. The lack of awareness in women about breast cancer in developing countries is retraining the market.

Request a Free Sample of our Global Breast Cancer Diagnostics And Therapeutics Market: https://www.omrglobal.com/request-sample/breast-cancer-diagnostics-therapeutics-market

Global breast cancer diagnosis and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/Computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others

A full Report of Global Breast Cancer Diagnostics And Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/breast-cancer-diagnostics-therapeutics-market

Global Breast Cancer Diagnostics and Therapeutics Market Segmentation

By Cancer type

• Ductal Carcinoma In-Situ (DCIS)
• Invasive Ductal Carcinoma (IDC)
• Triple Negative Breast Cancer (TNBC)
• Inflammatory Breast Cancer
• Others (Invasive lobular carcinoma)
By Diagnostics

• Mammography
• Biopsy
• PET/CET
• Ultrasound
• Others (MRI)
• Hospitals
By Therapeutics

• Chemotherapy
• Hormone Therapy
• Targeted Therapy
• Others (Radiation Therapy, Surgery)

Regional Analysis
• North America
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• AbbVie Inc.
• Agendia NV
• AstraZeneca PLC
• Astellas Pharma Inc.
• Bayer AG
• Bristol-Myers Squibb Co
• Eisai Co., Ltd.
• Eli Lilly and Co.
• GlaxoSmithKline PLC
• Halozyme, Inc
• Hologic Inc.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Mylan NV
• Novartis International AG
• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Sanofi S.A.
• Siemens Healthcare GmbH
• Takeda Pharmaceutical Co. Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/breast-cancer-diagnostics-therapeutics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.